Designing Program Success in Orphan Drug Development

Rare and genetic diseases affect one in 10 Americans, 30 million people in the United States, and 300 million people globally. Over 6,800 distinct rare diseases exist, with about 80 percent caused by faulty genes. Understanding the regulatory pathway and unique statistical approaches for orphan drug products are critical to a well-designed drug development program. More information and online registration is here.